Poviztra 1.7mg FlexTouch is used to:

• Manage obesity: It is used with a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity.

• Manage overweight with weight-related health conditions: It may be prescribed for adults with overweight who have at least one weight-related condition.

• Support cardiovascular risk reduction: Semaglutide is also indicated to reduce the risk of major adverse cardiovascular events in eligible adults with established cardiovascular disease and obesity or overweight.

Poviztra 1.7mg FlexTouch contains Semaglutide, which activates GLP-1 receptors involved in appetite and food intake regulation.

It helps increase fullness and reduce hunger and food intake. Semaglutide also slows stomach emptying, supporting appetite control when used with a reduced-calorie diet and increased physical activity.

Tell your doctor about all prescription medicines, over-the-counter medicines, vitamins and herbal supplements you take.

• Insulin or sulfonylureas: The risk of low blood sugar may increase when Semaglutide is used with these medicines.

• Other GLP-1 medicines or Semaglutide products: Do not combine Poviztra with another Semaglutide-containing medicine or GLP-1 receptor agonist unless prescribed by your doctor.

• Oral medicines: Semaglutide can delay stomach emptying and may affect the absorption of some medicines taken by mouth.

• Store Poviztra 1.7mg FlexTouch in a refrigerator at 2°C to 8°C.

• Do not freeze it or use it if it has been frozen.

• Protect the pen from light.

• Keep it out of the sight and reach of children.

• Follow the product packaging instructions for storage after first use.

Poviztra 1.7mg FlexTouch is injected once a week under the skin of the abdomen, thigh or upper arm.

The 1.7mg strength is used during dose escalation and is generally followed by the 2.4mg maintenance dose when appropriate. Your doctor may keep you at a lower dose for longer if you do not tolerate dose increases well.

Use the FlexTouch pen only after receiving proper instruction on the injection technique. Use a new needle for every injection and never share the pen.

If you miss a dose, follow the missed-dose instructions provided with your product and prescription. Do not take two doses together.

Common side effects:

• Nausea

• Vomiting

• Diarrhoea

• Constipation

• Abdominal pain

• Headache

• Dizziness

• Indigestion

• Decreased appetite

These effects may become more noticeable when the dose is increased.

Serious side effects:

• Severe or persistent abdominal pain

• Severe allergic reactions

• Persistent vomiting or diarrhoea with dehydration

• Gallstones or gallbladder inflammation

• Changes in vision

• Low blood sugar when used with insulin or sulfonylureas

Seek medical attention if severe or persistent symptoms develop.

• Follow the dose-escalation schedule given by your doctor.

• Do not increase the dose yourself because a higher dose is not necessarily better tolerated.

• Drink enough fluids if vomiting or diarrhoea occurs.

• Rotate injection sites between the abdomen, thigh and upper arm.

• Use a new needle for each injection.

• Do not share your FlexTouch pen.

• Tell your doctor before surgery or deep sedation.

• Report severe abdominal pain or new vision changes promptly.